These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 1492969

  • 1. A non-antibiotic antimicrobial mixture (C31G): evaluation of the antimicrobial efficiency of C31G on vaginal cultures.
    Calis S, Yulug N, Sumnu M, Ayhan A, Hincal AA.
    Boll Chim Farm; 1992 Oct; 131(9):335-8. PubMed ID: 1492969
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a surfactant mixture C31G as a teat dip by a modified excised teat model.
    Amin MM, Smith AR, Anderson KL, Hahn EC, Gustafsson BK.
    J Dairy Sci; 1984 Feb; 67(2):421-6. PubMed ID: 6425375
    [Abstract] [Full Text] [Related]

  • 3. Clinical study of a C31G containing mouthrinse: effect on salivary microorganisms.
    Corner AM, Brightman VJ, Cooper S, Yankell SL, Malamud D.
    J Clin Dent; 1990 Feb; 2(2):34-8. PubMed ID: 2090157
    [Abstract] [Full Text] [Related]

  • 4. Effect of suppository bases on the release properties of a potent antimicrobial agent (C31G).
    Caliş S, Sumnu M, Hincal AA.
    Pharmazie; 1994 May; 49(5):336-9. PubMed ID: 8016179
    [Abstract] [Full Text] [Related]

  • 5. Prolonged exposure to the candidate microbicide C31G differentially reduces cellular sensitivity to agent re-exposure.
    Catalone BJ, Ferguson ML, Miller SR, Malamud D, Kish-Catalone T, Thakkar NJ, Krebs FC, Howett MK, Wigdahl B.
    Biomed Pharmacother; 2005 Sep; 59(8):460-8. PubMed ID: 16154719
    [Abstract] [Full Text] [Related]

  • 6. A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II.
    Mauck CK, Weiner DH, Creinin MD, Barnhart KT, Callahan MM, Bax R.
    Contraception; 2004 Sep; 70(3):233-40. PubMed ID: 15325893
    [Abstract] [Full Text] [Related]

  • 7. Effect of C31G, an antimicrobial surfactant, on healing of incised guinea pig wounds.
    Michaels EB, Hahn EC, Kenyon AJ.
    Am J Vet Res; 1983 Jul; 44(7):1378-81. PubMed ID: 6881675
    [Abstract] [Full Text] [Related]

  • 8. Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes.
    Krebs FC, Miller SR, Catalone BJ, Welsh PA, Malamud D, Howett MK, Wigdahl B.
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1954-60. PubMed ID: 10858360
    [Abstract] [Full Text] [Related]

  • 9. C31G, a new agent for oral use with potent antimicrobial and antiadherence properties.
    Corner AM, Dolan MM, Yankell SL, Malamud D.
    Antimicrob Agents Chemother; 1988 Mar; 32(3):350-3. PubMed ID: 3364952
    [Abstract] [Full Text] [Related]

  • 10. Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G.
    Catalone BJ, Miller SR, Ferguson ML, Malamud D, Kish-Catalone T, Thakkar NJ, Krebs FC, Howett MK, Wigdahl B.
    Biomed Pharmacother; 2005 Sep; 59(8):430-7. PubMed ID: 16154721
    [Abstract] [Full Text] [Related]

  • 11. A phase I comparative postcoital testing study of three concentrations of C31G.
    Mauck CK, Creinin MD, Barnhart KT, Ballagh SA, Archer DF, Callahan MM, Schmitz SW, Bax R.
    Contraception; 2004 Sep; 70(3):227-31. PubMed ID: 15325892
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the interfacial properties of a new potent antimicrobial surfactant C31G.
    Unlü N, Caliş S, Sumnu M, Hincal AA.
    Boll Chim Farm; 1991 Jun; 130(6):234-8. PubMed ID: 1756007
    [Abstract] [Full Text] [Related]

  • 13. Assessment of the anti-microbial agent C31G as a spermicide: comparison with nonoxynol-9.
    Thompson KA, Malamud D, Storey BT.
    Contraception; 1996 May; 53(5):313-8. PubMed ID: 8724622
    [Abstract] [Full Text] [Related]

  • 14. Controlled wound repair in guinea pigs, using antimicrobials that alter fibroplasia.
    Kenyon AJ, Hamilton SG, Douglas DM.
    Am J Vet Res; 1986 Jan; 47(1):96-101. PubMed ID: 3946914
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and antimicrobial evaluation of new phenoxyacetamide derivatives.
    Raffa D, Migliara O, Daidone G, Maggio B, Schillaci D.
    Boll Chim Farm; 2002 Jan; 141(1):3-7. PubMed ID: 12064055
    [Abstract] [Full Text] [Related]

  • 16. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate.
    Krebs FC, Miller SR, Malamud D, Howett MK, Wigdahl B.
    Antiviral Res; 1999 Oct; 43(3):157-73. PubMed ID: 10551374
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and antimicrobial activity of N-(1,2-benzisothiazol-3-yl)amidines.
    Vicini P, Zani F.
    Farmaco; 1997 Jan; 52(1):21-4. PubMed ID: 9181676
    [Abstract] [Full Text] [Related]

  • 18. Effects of tonicity-adjusting and surfactant agents on the antimicrobial activity of alexidine.
    Yanai R, Ueda K, Nishida T, Toyohara M, Mori O.
    Eye Contact Lens; 2011 Mar; 37(2):57-60. PubMed ID: 21252685
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and antimicrobial activity evaluation of some new adamantane derivatives.
    Caliş U, Yarim M, Köksal M, Ozalp M.
    Arzneimittelforschung; 2002 Mar; 52(10):778-81. PubMed ID: 12442642
    [Abstract] [Full Text] [Related]

  • 20. Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging.
    Barnhart KT, Pretorius ES, Timbers K, Shera D, Shabbout M, Malamud D.
    Contraception; 2005 May; 71(5):357-61. PubMed ID: 15854637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.